Clinical Trial Update: A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer [Phase 2]

View source ↗

Summary

Phase II multicenter trial evaluating modified FOLFIRINOX as first-line therapy for advanced urachal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urachal Cancer

Drugs mentioned

• Modified FOLFIRINOX (modified FOLFIRINOX)

Snippet

Sponsor: Asan Medical Center | Conditions: Urachal Cancer | Phase 2 | Status: UNKNOWN